ezetimibe add-on to statin for effectiveness (EASE) trial

From Aaushi
Jump to navigation Jump to search

Introduction

Study characteristics:

  • community based, manufacturer sponsored, randomized trial
  • 3 of 6 authors employed by sponsor

3030 patients on statins at start of study

Treatment:

Results: (after 6 weeks)

More general terms

Additional terms

References

  1. Journal Watch 25(13):104, 2005 Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc. 2005 May;80(5):587-95. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15887425
    Hurley DL, Isley WL. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals. Mayo Clin Proc. 2005 May;80(5):585-6. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15887424